The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

Contact Radiotherapy for Rectal Cancer

Not phased · randomised · 110 people · 2 sites in Sweden · Recruiting now

August 11, 2026
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Phase 2 · 265 people · 16 sites in 2 countries · Recruiting now

August 11, 2026
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases

Phase 2 · 17 people · 1 site in United States · Recruiting now

August 11, 2026
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Phase 1 · 180 people · 3 sites in United States · Recruiting now

August 11, 2026
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 · randomised · 132 people · 15 sites in 2 countries · Recruiting now

August 11, 2026
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Phase 2 · 164 people · 1 site in United States · Recruiting now

August 11, 2026
Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Phase 2 · 64 people · 4 sites in United States · Recruiting now

August 11, 2026
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Phase 1 · 392 people · 44 sites in 6 countries · Recruiting now

August 11, 2026
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Phase 2 · 20 people · 3 sites in United States · Recruiting now

August 11, 2026
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer

Phase 3 · randomised · 550 people · 2 sites in China · Recruiting now

August 11, 2026